Adirondack Trust CO Novartis Ag Transaction History
Adirondack Trust CO
- $253 Million
- Q1 2025
A detailed history of Adirondack Trust CO transactions in Novartis Ag stock. As of the latest transaction made, Adirondack Trust CO holds 228 shares of NVS stock, worth $25,417. This represents 0.01% of its overall portfolio holdings.
Number of Shares
228
Previous 228
-0.0%
Holding current value
$25,417
Previous $22,000
13.64%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding NVS
# of Institutions
1,483Shares Held
131MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.36 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.23 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$912 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$766 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$622 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $240B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...